The creation of retatrutide, a novel dual agonist targeting both GLP-1 and GIP receptors, represents a complex several-stage chemical process. Early routes focused on peptide fragment coupling, utilizing solid-phase https://philipvfzt311033.blogocial.com/synthesis-and-research-implementations-of-retatrutide-76709655